SecBot SecBot
Insider Cluster (2 insiders) ·Filed Apr 23, 2026

IMVT

Immunovant, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $845K total
Actionable Insight • Neutral

Monitor upcoming Form 4 filings and the next 10-Q for any changes in guidance or liquidity trends. While this level of selling is not material relative to market cap, the participation of the CFO and CTO warrants attention if additional sales follow.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
IMVT ▲ +38.08% at T+60d
NEUTRAL call +38.08% · α vs SPY +33.07% · entry $28.91 → $39.92
Entry = T+0 close
Apr 22, 2026
via day close
T+1d
-1.14%
call -1.14% · α -1.93%
$28.58
settled 6mo ago
T+5d
-6.78%
call -6.78% · α -8.26%
$26.95
settled 6mo ago
T+20d
+23.00%
call +23.00% · α +18.37%
$35.56
settled 5mo ago
T+60d
+38.08%
call +38.08% · α +33.07%
$39.92
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Two C-suite executives at Immunovant — the CFO and CTO — sold shares worth $845,000 in open-market transactions on April 23, 2026, at $29.62 per share. This represents modest insider selling from key executives, totaling approximately 0.014% of the company's $5.9B market cap.

Key Financial Metrics

Direction
selling
Total Value
$845.0K
Insiders
2

Key Facts

  • CFO Girao Tiago sold 25,760 shares for $763,011.
  • CTO Jay S. Stout sold 2,754 shares for $81,573.
  • Both transactions occurred on April 23, 2026, at $29.62 per share.
  • Total insider selling cluster value: $845,000.
  • Selling represents 0.014% of Immunovant’s $5.9B market capitalization.

Financial Impact

$845,000 in total open-market sales by two C-suite executives

insider ownershipshareholder sentiment

Risk Factors

  • Perception of insider lack of confidence, especially given both sellers are C-suite executives.
  • Potential for increased scrutiny if further selling occurs near-term.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IMVT-1777061270615
12 reports for IMVT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for IMVT — sortable, filterable
TypeNow
Aug 6, 2026
11w ago
8-K
BEARISH ★ 6/10
$39.74 $39.12▲ +1.56%▲ +2.16%$27.68 (+30.35%)
Jul 24, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$40.09 $43.32▲ +8.06%▲ +4.76%$27.68 (−30.96%)
Jun 26, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
144
NEUTRAL ★ 2/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
144
NEUTRAL ★ 4/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 15, 2026
18w ago
144
NEUTRAL ★ 2/10
$33.61 $38.77▲ +15.35%▲ +15.15%$27.68 (−17.64%)
May 28, 2026
21w ago
144
NEUTRAL ★ 3/10
$33.30 $38.51▲ +15.65%▲ +17.44%$27.68 (−16.88%)
May 20, 2026
22w ago
8-K
MIXED ★ 6/10
$35.56 $35.34▼ −0.62%▼ −1.36%$27.68 (−22.16%)
May 20, 2026
22w ago
Press Release
BULLISH ★ 7/10
$35.56 $35.34▼ −0.62%▼ −1.36%$27.68 (−22.16%)
Showing 10 of 12

US Market Status

Market Open — Closes in 5h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026